Remifentanil Dosing at Extremes of Body Weight

Affiliations

¹ From the Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, California (S.L.S.) and the "P Less Than" Company, San Francisco, California (D.M.F.).

Editorial

Steven L Shafer et al. Anesthesiology. 2017 Jun.

. 2017 Jun;126(6):993-994.

doi: 10.1097/ALN.0000000000001636.

¹ From the Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, California (S.L.S.) and the "P Less Than" Company, San Francisco, California (D.M.F.).

No abstract available

Comment on

An Allometric Model of Remifentanil Pharmacokinetics and Pharmacodynamics.
Eleveld DJ, Proost JH, Vereecke H, Absalom AR, Olofsen E, Vuyk J, Struys MMRF. Eleveld DJ, et al. Anesthesiology. 2017 Jun;126(6):1005-1018. doi: 10.1097/ALN.0000000000001634. Anesthesiology. 2017. PMID: 28509794
Disposition of Remifentanil in Obesity: A New Pharmacokinetic Model Incorporating the Influence of Body Mass.
Kim TK, Obara S, Egan TD, Minto CF, La Colla L, Drover DR, Vuyk J, Mertens M; the Remifentanil Pharmacokinetics in Obesity Investigators. Kim TK, et al. Anesthesiology. 2017 Jun;126(6):1019-1032. doi: 10.1097/ALN.0000000000001635. Anesthesiology. 2017. PMID: 28509796